Publiziert in: Marktpuls, Unternehmen
Frei

Roche Investor Update: Reminder: Invitation to Roche's Half Year Results 2016 Donnerstag, 14. Juli 2016 - 14:03

Roche - Investor Update

Basel, 14 July 2016
Invitation to Roche's Half Year Results 2016
Roche will publish its Half Year Results for 2016 prior to the opening of the Swiss Stock Exchange on 21st July, 2016.
We would like to invite you to watch the live video webcast or to dial in as outlined below:
Up

Thursday, 21st July, 2016


13:00 - 14:30 CEST / 12:00 - 13:30 BST
07:00 - 08:30 AM EDT / 04:00 - 05:30 AM PDT

Live video webcast and conference call will start with presentations by senior management followed by a Q&A session (questions can be asked via phone and webcast).

Presenters:

Severin Schwan, CEO Roche Group
Alan Hippe, Chief Financial and IT Officer
Daniel O'Day, CEO Roche Pharmaceuticals
Roland Diggelmann, CEO Roche Diagnostics
Download this event to your calendar > click here

To access the live video webcast, please > click here and access the webcast under "Current Events".

To listen to the conference call, please dial in to the conference 10-15 min prior to the scheduled start, using the following numbers:
+41 (0) 58 310 5000 (Europe and ROW)
+44 (0) 203 059 5862 (UK)
+1 (1) 631 570 5613 (USA Toll Free)

To expedite the registration process on the day of the conference call, you may pre-register for the event> click here

A replay of the webcast will be available on demand on the Roche website. > click here

 
Best regards,
Karl Mahler
Head of Investor Relations
Up
Roche Investor Relations
Dr. Karl Mahler 
Phone: +41 61 68-78503 
e-mail: karl.mahler@roche.com
Dr. Sabine Borngräber 
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com
Dr. Bruno Eschli 
Phone: +41 61 68-75284 
e-mail: bruno.eschli@roche.com
Dr. Tamer Farhan 
Phone: +41 61 68-82552 
e-mail: tamer.farhan@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814 
e-mail: birgit.masjost@roche.com
 
Investor Relations North America
Neera Dahiya Ravindran, MD 
Phone: +1 650 491 5281 
e-mail: ravindran.neera@gene.com
Nina Goworek 
Phone: +1 650 467-8737 
e-mail: goworek.nina@gene.com
14 July, 2016 Content owner:   Roche Investor Relations    ©2016 F. Hoffmann-La Roche Ltd.